FDA Approvals Roundup: Qwo, Tremfya, Dysport

New approvals
Qwo nabs approval for first injectable cellulite treatment
Endo International’s Qwo (collagenase clostridium histolyticum-aaes [CCH] injection) has been approved as the first injectable therapy for moderate to severe cellulite in adult women.